News
7don MSN
The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...
1d
MedPage Today on MSNNew Advisor to FDA Chief Pushed Back on COVID PoliciesTracy Beth Høeg, MD, PhD, who was named a special assistant to new FDA Commissioner Marty Makary, MD, MPH, previously opposed ...
A pair of new studies finds no significant benefit of the antiviral drug nirmatrelvir-ritonavir (Paxlovid) in alleviating the ...
2d
HealthDay on MSNFDA Delays Final Approval of Novavax COVID VaccineThe decision had been expected by April 1, but the agency now says it needs more information before moving forward.
Dr. Peter Marks, a top official at the Food and Drug Administration who helped lead the U.S. effort to rapidly develop ...
The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.
The FDA delays full approval for Novavax's COVID-19 vaccine, citing the need for additional data. Read more here.
The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on track to be cleared until Tuesday afternoon, a person familiar with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results